5-Amino-1MQ Specification and Vial Format Review walks through 5-Amino-1MQ (5mg / 10mg / 50mg) documentation, vial format, and buyer workflow for Metabolic Research laboratories using sulanpeptide.vip.
5-Amino-1MQ is a cell-permeable small-molecule NNMT inhibitor used in laboratory research on metabolic regulation. NNMT links nicotinamide methylation with cellular energy pathways, and 5-Amino-1MQ is commonly studied in models involving adipose-tissue metabolism, NAD+ biology, and mitochondrial energy balance.
Common laboratory readouts include NNMT enzymatic activity assays, NAD+ quantification kits, and oxygen-consumption rate measurements in differentiated adipocyte lines treated with graded inhibitor concentrations. Mouse diet-induced obesity models in research settings have been used to examine how NNMT inhibition affects white-adipose gene-expression panels—always within approved animal research protocols.
Peer-reviewed work on NNMT inhibitors discusses adipocyte energy expenditure markers and mitochondrial biogenesis transcripts rather than consumer weight outcomes. NNMT (nicotinamide N-methyltransferase) methylates nicotinamide and influences NAD+ salvage flux in adipocytes and hepatocyte models. 5-Amino-1MQ blocks NNMT activity in cell culture, shifting nicotinamide toward NAD+ biosynthesis rather than 1-methylnicotinamide production.
Published metabolic research often measures NNMT expression by qPCR in adipose-tissue explants and correlates inhibitor treatment with changes in NAD+/NADH ratios using luminescence-based assays.
Side-by-side review of specification table, vial label, and COA prevents release errors for 5-Amino-1MQ. Principal investigators should sign off 5-Amino-1MQ SKUs only after mechanism fit is documented in the study protocol.
Spec alignment: Enter exact strength notation (5mg / 10mg / 50mg) in procurement systems—do not round kit counts.
Catalog identifiers for 5-Amino-1MQ: CAS 42464-96-0, Formula: C10H11N2+. MW 159.21 g/mol, purity target ≥ 99.0%. Copy these fields into requisitions and match them line-by-line on incoming COA PDFs.
Publication methods should list Cat No. and mg strength for 5-Amino-1MQ to support reproducibility.
Dose planning for 5-Amino-1MQ should state mass (5mg / 10mg / 50mg) or molarity derived from catalog molecular weight.
Side-by-side review of catalog specification table, quote confirmation, vial label, and COA prevents release errors for 5-Amino-1MQ. QA sign-off should reference all four documents in the batch record. Purity target ≥ 99.0% on the catalog is a specification goal. Release criteria for 5-Amino-1MQ should state whether the lot COA must meet or exceed that threshold for your Metabolic Research assay type.
Specification alignment for 5-Amino-1MQ requires copying exact kit notation (5mg / 10mg / 50mg) into ERP or LIMS systems. Rounding “10mg×10 vials” to “100mg total” causes mismatches when COA lists per-vial strength and suppliers ship multi-vial kits. Molecular identifiers for 5-Amino-1MQ—CAS 42464-96-0, molecular weight, and formula when listed—should appear on internal sample labels alongside Cat No. Publications citing 5-Amino-1MQ should include these fields for reproducibility in Metabolic Research journals.
Format selection for 5-Amino-1MQ affects reconstitution math and aliquot planning. Compare available vial strengths on sulanpeptide.vip against protocol dose ranges before leadership approves a SKU; changing strength mid-study complicates comparability.
Molecular identifiers for 5-Amino-1MQ—CAS 42464-96-0, molecular weight, and formula when listed—should appear on internal sample labels alongside Cat No. Publications citing 5-Amino-1MQ should include these fields for reproducibility in Metabolic Research journals. Format selection for 5-Amino-1MQ affects reconstitution math and aliquot planning. Compare available vial strengths on sulanpeptide.vip against protocol dose ranges before leadership approves a SKU; changing strength mid-study complicates comparability.
Specification alignment for 5-Amino-1MQ requires copying exact kit notation (5mg / 10mg / 50mg) into ERP or LIMS systems. Rounding “10mg×10 vials” to “100mg total” causes mismatches when COA lists per-vial strength and suppliers ship multi-vial kits.
5-Amino-1MQ from Sulan Peptide Official is for research use only (RUO)—not for human or veterinary use. Questions: Contact page or WhatsApp on sulanpeptide.vip.